Key result
Late Aspergillus endocarditis complicates transcatheter ASD closure, carrying ~80% mortality.
Why the study?
Late-onset device-related infective endocarditis is a rare but life-threatening complication following percutaneous ASD closure, and fungal cases carry a mortality exceeding 80% largely due to delayed diagnosis and limited therapeutic options.
Case Report (n=1)
No
This case report highlights the high mortality and diagnostic challenges of late-onset fungal infective endocarditis occurring years after percutaneous atrial septal defect device closure, underscoring the need for long-term clinical surveillance in patients with persistent unexplained fever.
Answers are grounded in this paper and cite their sources.
May warrant fungal endocarditis evaluation in unexplained fever years after ASD closure; leaves open optimal long-term surveillance protocols.
Late-onset device-related infective endocarditis (IE) is a rare but life-threatening complication following percutaneous atrial septal defect (ASD) closure. Fungal IE, although uncommon, carries a mortality exceeding 80%, largely due to delayed diagnosis and limited therapeutic options. A 24-year-old woman with a history of transcatheter ASD device closure 2 years earlier presented with a 2-month history of fever, dyspnea, weight loss, and pleuritic chest pain. Transthoracic echocardiography demonstrated large vegetations on the right atrial aspect of the device. Computed tomography of the chest revealed cavitary lung lesions with intracavitary fungal balls, and serum galactomannan levels were markedly elevated. Despite initiation of antifungal therapy, she developed massive pulmonary embolism and succumbed to her illness before surgical removal of the device could be performed. This case highlights the diagnostic and therapeutic challenges associated with late device-related IE following ASD closure. Although rare, IE should be considered even years after device implantation in patients presenting with persistent, unexplained fever. Fungal endocarditis in device recipients, though uncommon, is associated with extremely high mortality and underscores the need for long-term clinical surveillance.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (2026) conducted a case report in Late-onset Aspergillus infective endocarditis after atrial septal defect device closure (n=1). Transcatheter atrial septal defect device closure and antifungal therapy was evaluated on Clinical survival and resolution of fungal endocarditis. Transcatheter ASD device closure can be complicated 2 years post-implantation by fatal Aspergillus endocarditis, a condition carrying >80% mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: